U.S. Telecom Services and Carriers Stock News

RXO (RXO) has been hit by a sharp selloff after weaker fourth quarter results, a Ba1 credit rating downgrade, and the pricing of a US$400 million senior notes refinancing that raised fresh questions about credit risk. See our latest analysis for RXO. The stock’s recent swings reflect that tension clearly, with a 1 day share price return of 4% after a 7 day share price decline of 17.57%, a 90 day share price return of 23.27%, and a 1 year total shareholder return decline of 38.84%, suggesting...

Otter Tail (OTTR) shares are in focus after the company released fourth quarter and full year 2025 results, reporting slightly lower earnings alongside higher sales, and issued new 2026 diluted EPS guidance. See our latest analysis for Otter Tail. The earnings release and new 2026 guidance have come as Otter Tail’s share price has been firming, with a recent 90 day share price return of 7.87% and a five year total shareholder return of 140.97%. This suggests momentum has built over time from...

Westinghouse Air Brake Technologies (WAB) is back in focus after securing multihundred-million-dollar locomotive deals with Union Pacific and CSX, updating its 2026 sales guidance and expanding its remaining share repurchase authorization. See our latest analysis for Westinghouse Air Brake Technologies. The recent Union Pacific and CSX locomotive agreements, updated 2026 sales guidance in the US$12.19b to US$12.49b range, stepped-up buybacks and a dividend increase come as the share price has...

Callaway Golf (CALY) is under pressure after fourth quarter revenue missed analyst expectations, and management issued 2026 guidance that points to lower sales and profitability than the market was looking for. See our latest analysis for Callaway Golf. The disappointing quarter and softer 2026 guidance have reversed much of Callaway Golf's recent momentum, with a 1 day share price return of a 15.05% decline to US$12.59 and a 7 day share price return of a 14.06% decline, even though the 90...

MannKind (MNKD) is back in focus after enrolling the first pediatric patient in its INHALE-1ST Afrezza study and advancing an FDA review that could make Afrezza the first needle-free insulin option for children. See our latest analysis for MannKind. The latest Afrezza pediatric milestones come as MannKind’s 30 day share price return of 8.64% and 90 day share price return of 13.20% point to building momentum, while its 1 year total shareholder return of 4.43% and 5 year total shareholder...

AerCap Holdings (NYSE:AER) has drawn fresh attention after reporting full year 2025 results, raising its quarterly dividend to $0.40 per share and completing sizeable share repurchases alongside new fleet moves with Frontier Group Holdings. See our latest analysis for AerCap Holdings. The recent earnings release, higher dividend and active buyback program appear to align with solid momentum in the shares, with a 90 day share price return of 13.57% and a 1 year total shareholder return of...

Romania has approved the final investment decision for Europe's first NuScale (NYSE:SMR) small modular reactor power plant. The project will start with one of six planned SMR units, which is intended to serve as a reference for future expansion. NuScale also announced a collaboration with Oak Ridge National Laboratory to apply artificial intelligence to nuclear fuel management across multiple reactors. NuScale Power, listed as NYSE:SMR, focuses on small modular reactors designed to provide...

If you are wondering whether GoDaddy's current share price reflects its true worth, this article will walk you through what the market is pricing in and how that compares with a range of valuation checks. The stock closed at US$89.12, with a 7.3% decline over the last 7 days, a 14.7% decline over the last 30 days, a 24.8% decline year to date, and a 50.8% decline over the past year, while still showing 16.9% and 9.1% returns over the last 3 and 5 years respectively. Recent coverage has...

In February 2026, Regeneron Pharmaceuticals announced that 36 abstracts from its immunology and inflammation portfolio were presented at the AAAAI Annual Meeting, including first Phase 3 data on antibody cocktails targeting cat and birch allergens to ease ocular allergy symptoms. The breadth of data, ranging from novel allergen-specific antibodies to new Dupixent analyses in dermatological, respiratory, and gastrointestinal diseases, underlines how Regeneron is trying to broaden its allergy...

Ultragenyx Pharmaceutical (NasdaqGS:RARE) is facing multiple shareholder class action lawsuits tied to allegations of misleading disclosures about Phase III clinical trial data. The lawsuits follow the company’s announcement of failed Phase III trials alongside a broad restructuring plan that includes layoffs. At the same time, Ultragenyx reported positive long term data for its investigational gene therapy UX111 and advanced regulatory submissions. Ultragenyx focuses on therapies for rare...

DTE Energy (DTE) heads into its February 17 quarterly earnings call with attention on two fronts: fresh operating earnings guidance and how management is executing on a 1.4 GW data center power agreement. See our latest analysis for DTE Energy. The recent 2.9% 1 day share price return, building on an 11.2% year to date share price return and a 15.7% 1 year total shareholder return, suggests interest is firming as investors weigh earnings guidance, data center demand, and DTE Energy’s grid and...

Royal Gold (RGLD) is back on investors’ radar after a period of accelerating revenue and earnings growth, coupled with what is described as best in class profitability and a confirmed stock uptrend. See our latest analysis for Royal Gold. Royal Gold’s share price has climbed to US$286.10 after a 51.8% 90 day share price return and a 93.7% 1 year total shareholder return, pointing to strong momentum as investors reassess growth prospects and perceived risk. If this kind of run in a precious...

Viking Therapeutics has completed enrollment in its Phase 3 VANQUISH-1 trial of injectable VK2735 for obesity. The company plans to advance its oral VK2735 obesity candidate into Phase 3 trials. Viking also intends to file an IND for a new amylin agonist program targeting obesity. Viking Therapeutics, ticker NasdaqCM:VKTX, is pushing deeper into obesity treatment with multiple assets now moving through late stage development. The stock trades at $29.0, with a return of 162.9% over three...

Ameriprise Financial (AMP) has moved onto investor watchlists after announcing that Joseph E. Sweeney, President of Advice & Wealth Management Products & Service Delivery, plans to retire on April 3, 2026, from this key leadership role. See our latest analysis for Ameriprise Financial. Ameriprise’s latest leadership news comes after a mixed stretch for the stock, with a 1-day share price return of 1.36% to US$473.67, a 30-day share price return reflecting a 7% decline, and a 1-year total...

Wasatch Global Investors recently highlighted RBC Bearings (NYSE:RBC) as a core holding, citing continued strong execution and a positive outlook. Company management pointed to robust aerospace and defense demand, with strength from submarine, missile, and aircraft programs. RBC Bearings also reported an increased share of business with Airbus, indicating deeper involvement in commercial aerospace platforms. RBC Bearings, a supplier of engineered bearings and components, sits at the...

DexCom (DXCM) has just reported Q4 2025 results that topped consensus on both revenue and earnings, supported by uptake of its G7 15 day system, broader use of Stelo, and a focus on margins. See our latest analysis for DexCom. The latest Q4 beat and renewed 2026 guidance arrived alongside a 1 day share price return of 7.59%. However, the 1 year total shareholder return of 22.66% and 5 year total shareholder return of 31.15% show that longer term performance has lagged, so recent momentum is...

If you are wondering whether NVIDIA's share price still makes sense after all the headlines, this article walks through what the current market price might be implying about the company. NVIDIA shares last closed at US$182.81, with returns of a 3.0% decline over the past week, a 1.8% decline over the last month, a 3.2% decline year to date, and a 31.2% gain over the past year, on top of a very large 3 year return and a gain of more than 10x over 5 years. Recent news flow has continued to...

With no single headline event driving the move, Silgan Holdings (SLGN) has drawn attention after a month and past 3 months of positive share performance, prompting investors to reassess its packaging-focused business. See our latest analysis for Silgan Holdings. The recent 30-day share price return of 13.51% and 90-day share price return of 27.93% contrast with a 1-year total shareholder return decline of 8.65%. This suggests momentum in the share price while longer term holders have had a...

If you are wondering whether Adobe’s current share price lines up with its underlying worth, you are not alone. This article is here to walk you through that question clearly. Adobe shares last closed at US$263.97, with returns of 0.3% decline over 7 days, 10.9% decline over 30 days, 20.8% decline year to date, 43.1% decline over 1 year, and 23.9% decline over 3 years, while the 5 year return sits at 43.6% decline. Recent coverage around Adobe has focused on how investors are reassessing...

Highwoods Properties (HIW) has kicked off a US$300 million at the market follow-on equity offering, shortly after reporting its fourth quarter and full year 2025 earnings and outlining its acquisition and development plans. See our latest analysis for Highwoods Properties. The at the market program and recent earnings update come after a 16.05% 30 day share price decline and a 15.65% 1 year total shareholder return decline, while the 3 year total shareholder return is slightly positive,...

Ryder System, Inc. recently reported its fourth-quarter and full-year 2025 results, showing broadly steady revenue and earnings, while also confirming a regular US$0.91 quarterly dividend and completing share repurchases totaling 2.44% of its stock for US$202.10 million under the October 23, 2025 buyback. The company also issued 2026 guidance that points to modest 1% total revenue growth and detailed GAAP EPS ranges, giving investors clearer visibility into expected profitability for both...

If you are wondering whether Wendy's current share price reflects its true worth, you are not alone. This article is built to help you make sense of what you are paying for. The stock closed at US$7.48, with returns of a 4.3% decline over 7 days, 10.1% decline over 30 days, 8.4% decline year to date, 47.1% decline over 1 year, 60.9% decline over 3 years and 54.4% decline over 5 years. This performance may catch the eye of investors thinking about a potential reset in expectations. Recent...

If you are wondering whether PNC Financial Services Group is still fairly priced after its recent run, this article will walk through what the current share price might be implying about value. PNC shares last closed at US$229.32, after a 4.6% decline over the past 7 days, while the stock shows returns of 2.8% over 30 days, 8.4% year to date, 20.9% over 1 year, 66.3% over 3 years, and 58.7% over 5 years. Recent coverage of PNC has focused on the broader banking sector and how large regional...

The market rallied behind Byrna Technologies Inc.'s ( NASDAQ:BYRN ) stock, leading do a rise in the share price after...